首页> 外国专利> Derivatives of pyrrolidine compounds 1,4 - heterosustituidos, Preparation procedure,Pharmaceutical Composition and its use in the prophylaxis and Treatment of disorders caused by the activity of the Endothelin converting Enzyme (ECE) and Myocardial Ischemia.Hypertension and Asthma.

Derivatives of pyrrolidine compounds 1,4 - heterosustituidos, Preparation procedure,Pharmaceutical Composition and its use in the prophylaxis and Treatment of disorders caused by the activity of the Endothelin converting Enzyme (ECE) and Myocardial Ischemia.Hypertension and Asthma.

机译:吡咯烷化合物1,4-异硬脂酸衍生物,制备方法,药物组合物及其在预防和治疗由内皮素转化酶(ECE)和心肌缺血,高血压和哮喘引起的疾病中的用途。

摘要

The present Invention relates to compounds of the formula I wherein R1, R2, R3, R4.R5 and x are as defined in the description and Claims, and esters and / or the pharmaceutically acceptable salts of the same.The compounds are useful as inhibitors of metalloproteases, e.g.Zinc proteases, in particular zinc Hydrolases, and which are effective in the treatment of Disease States associated with the increasing incidents of vaso constriction.
机译:本发明涉及式I化合物,其中R 1,R 2,R 3,R 4,R 5和x如说明书和权利要求书中所定义,及其酯和/或药学上可接受的盐。金属蛋白酶的抑制剂,例如锌蛋白酶,特别是锌水解酶,可有效治疗与血管收缩事件增加有关的疾病状态。

著录项

  • 公开/公告号CL2001001704A1

    专利类型

  • 公开/公告日2002-07-09

    原文格式PDF

  • 申请/专利权人 F. HOFFMANN-LA ROCHE AG.;

    申请/专利号CL2001001704

  • 申请日2001-07-18

  • 分类号A61K31/422;A61K31/4709;A61P11/06;A61P9/00;A61P9/10;A61P9/12;C07D207/16;C07D215/16;C07D261/10;C07D401/12;C07D405/12;C07D409/12;C07D413/12;A61K21/401;

  • 国家 CL

  • 入库时间 2022-08-22 00:45:54

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号